Market Cap : 38.69 B | Enterprise Value : 37.82 B | PE Ratio : 79.22 | PB Ratio : 21.05 |
---|
NAS:DXCM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:DXCM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
DexCom's quarterly accounts payable & accrued expense increased from Jun. 2020 ($383 Mil) to Sep. 2020 ($489 Mil) and increased from Sep. 2020 ($489 Mil) to Dec. 2020 ($595 Mil).
DexCom's annual accounts payable & accrued expense increased from Dec. 2018 ($220 Mil) to Dec. 2019 ($345 Mil) and increased from Dec. 2019 ($345 Mil) to Dec. 2020 ($595 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
No Headline